VERV
Verve Therapeutics
VERV
VERV
Delisted
VERV was delisted on the 24th of July, 2025.
121 hedge funds and large institutions have $1.16B invested in Verve Therapeutics in 2023 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 49 increasing their positions, 37 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
2.41% less ownership
Funds ownership: 102.34% → 99.94% (-2.4%)
3% less funds holding
Funds holding: 125 → 121 (-4)
21% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 19
Holders
121
Holding in Top 10
3
Calls
$1.35M
Puts
$981K
Top Buyers
| 1 | +$12.5M | |
| 2 | +$11M | |
| 3 | +$11M | |
| 4 |
BlackRock
New York
|
+$5.63M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$5.08M |
Top Sellers
| 1 | -$14.6M | |
| 2 | -$13.1M | |
| 3 | -$8.87M | |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$8.06M |
| 5 |
Citigroup
New York
|
-$7.58M |